Selected research
Industry Research
Glass Vial for Vaccine Industry Research Report 2026
Market perspective
The global Glass Vial for Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glass Vial for Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glass Vial for Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glass Vial for Vaccine include Schott AG, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma and Piramal Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glass Vial for Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glass Vial for Vaccine Market by Company
Schott AG
DWK Life Sciences
Richland Glass
Nipro
Pacific Vial Manufacturing
Origin Ltd
Stevanato Group
SGD Pharma
Piramal Glass
Zheng Chuan
Shandong Pharmaceutical Glass
Zheng Li
Gerresheimer
Four Stars Glass
JOTOP Glass
Glass Vial for Vaccine Segment by Type
Molded Glass Vial
Tubular Glass Vial
Glass Vial for Vaccine Segment by Application
Preventive Vaccine
Therapeutic Vaccine
Glass Vial for Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glass Vial for Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glass Vial for Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glass Vial for Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glass Vial for Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glass Vial for Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glass Vial for Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Molded Glass Vial
- Tubular Glass Vial
Applications
- Preventive Vaccine
- Therapeutic Vaccine
Companies covered
- Schott AG
- DWK Life Sciences
- Richland Glass
- Nipro
- Pacific Vial Manufacturing
- Origin Ltd
- Stevanato Group
- SGD Pharma
- Piramal Glass
- Zheng Chuan
- Shandong Pharmaceutical Glass
- Zheng Li
- Gerresheimer
- Four Stars Glass
- JOTOP Glass
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glass Vial for Vaccine Market Size (2021-2032)
- 2.2.2 Global Glass Vial for Vaccine Sales (2021-2032)
- 2.2.3 Global Glass Vial for Vaccine Market Average Price (2021-2032)
- 2.3 Glass Vial for Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Molded Glass Vial
- 2.3.3 Tubular Glass Vial
- 2.4 Glass Vial for Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Preventive Vaccine
- 2.4.3 Therapeutic Vaccine
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glass Vial for Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glass Vial for Vaccine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Glass Vial for Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Glass Vial for Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Glass Vial for Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glass Vial for Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glass Vial for Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Glass Vial for Vaccine, Established Date
- 3.9 Global Glass Vial for Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Schott AG
- 4.1.1 Schott AG Company Information
- 4.1.2 Schott AG Business Overview
- 4.1.3 Schott AG Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Schott AG Glass Vial for Vaccine Product Portfolio
- 4.1.5 Schott AG Recent Developments
- 4.2 DWK Life Sciences
- 4.2.1 DWK Life Sciences Company Information
- 4.2.2 DWK Life Sciences Business Overview
- 4.2.3 DWK Life Sciences Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 DWK Life Sciences Glass Vial for Vaccine Product Portfolio
- 4.2.5 DWK Life Sciences Recent Developments
- 4.3 Richland Glass
- 4.3.1 Richland Glass Company Information
- 4.3.2 Richland Glass Business Overview
- 4.3.3 Richland Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Richland Glass Glass Vial for Vaccine Product Portfolio
- 4.3.5 Richland Glass Recent Developments
- 4.4 Nipro
- 4.4.1 Nipro Company Information
- 4.4.2 Nipro Business Overview
- 4.4.3 Nipro Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nipro Glass Vial for Vaccine Product Portfolio
- 4.4.5 Nipro Recent Developments
- 4.5 Pacific Vial Manufacturing
- 4.5.1 Pacific Vial Manufacturing Company Information
- 4.5.2 Pacific Vial Manufacturing Business Overview
- 4.5.3 Pacific Vial Manufacturing Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pacific Vial Manufacturing Glass Vial for Vaccine Product Portfolio
- 4.5.5 Pacific Vial Manufacturing Recent Developments
- 4.6 Origin Ltd
- 4.6.1 Origin Ltd Company Information
- 4.6.2 Origin Ltd Business Overview
- 4.6.3 Origin Ltd Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Origin Ltd Glass Vial for Vaccine Product Portfolio
- 4.6.5 Origin Ltd Recent Developments
- 4.7 Stevanato Group
- 4.7.1 Stevanato Group Company Information
- 4.7.2 Stevanato Group Business Overview
- 4.7.3 Stevanato Group Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Stevanato Group Glass Vial for Vaccine Product Portfolio
- 4.7.5 Stevanato Group Recent Developments
- 4.8 SGD Pharma
- 4.8.1 SGD Pharma Company Information
- 4.8.2 SGD Pharma Business Overview
- 4.8.3 SGD Pharma Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SGD Pharma Glass Vial for Vaccine Product Portfolio
- 4.8.5 SGD Pharma Recent Developments
- 4.9 Piramal Glass
- 4.9.1 Piramal Glass Company Information
- 4.9.2 Piramal Glass Business Overview
- 4.9.3 Piramal Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Piramal Glass Glass Vial for Vaccine Product Portfolio
- 4.9.5 Piramal Glass Recent Developments
- 4.10 Zheng Chuan
- 4.10.1 Zheng Chuan Company Information
- 4.10.2 Zheng Chuan Business Overview
- 4.10.3 Zheng Chuan Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zheng Chuan Glass Vial for Vaccine Product Portfolio
- 4.10.5 Zheng Chuan Recent Developments
- 4.11 Shandong Pharmaceutical Glass
- 4.11.1 Shandong Pharmaceutical Glass Company Information
- 4.11.2 Shandong Pharmaceutical Glass Business Overview
- 4.11.3 Shandong Pharmaceutical Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shandong Pharmaceutical Glass Glass Vial for Vaccine Product Portfolio
- 4.11.5 Shandong Pharmaceutical Glass Recent Developments
- 4.12 Zheng Li
- 4.12.1 Zheng Li Company Information
- 4.12.2 Zheng Li Business Overview
- 4.12.3 Zheng Li Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zheng Li Glass Vial for Vaccine Product Portfolio
- 4.12.5 Zheng Li Recent Developments
- 4.13 Gerresheimer
- 4.13.1 Gerresheimer Company Information
- 4.13.2 Gerresheimer Business Overview
- 4.13.3 Gerresheimer Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Gerresheimer Glass Vial for Vaccine Product Portfolio
- 4.13.5 Gerresheimer Recent Developments
- 4.14 Four Stars Glass
- 4.14.1 Four Stars Glass Company Information
- 4.14.2 Four Stars Glass Business Overview
- 4.14.3 Four Stars Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Four Stars Glass Glass Vial for Vaccine Product Portfolio
- 4.14.5 Four Stars Glass Recent Developments
- 4.15 JOTOP Glass
- 4.15.1 JOTOP Glass Company Information
- 4.15.2 JOTOP Glass Business Overview
- 4.15.3 JOTOP Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 JOTOP Glass Glass Vial for Vaccine Product Portfolio
- 4.15.5 JOTOP Glass Recent Developments
5 Global Glass Vial for Vaccine Market Scenario by Region
- 5.1 Global Glass Vial for Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glass Vial for Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Glass Vial for Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Glass Vial for Vaccine Sales by Region: 2027-2032
- 5.3 Global Glass Vial for Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Glass Vial for Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Glass Vial for Vaccine Revenue by Region: 2027-2032
- 5.4 North America Glass Vial for Vaccine Market Facts & Figures by Country
- 5.4.1 North America Glass Vial for Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glass Vial for Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Glass Vial for Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glass Vial for Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Glass Vial for Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glass Vial for Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Glass Vial for Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glass Vial for Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glass Vial for Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glass Vial for Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glass Vial for Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glass Vial for Vaccine Market Facts & Figures by Country
- 5.7.1 South America Glass Vial for Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glass Vial for Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Glass Vial for Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Glass Vial for Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glass Vial for Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glass Vial for Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glass Vial for Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glass Vial for Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Glass Vial for Vaccine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Glass Vial for Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Glass Vial for Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Glass Vial for Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glass Vial for Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Glass Vial for Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glass Vial for Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Glass Vial for Vaccine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Glass Vial for Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Glass Vial for Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Glass Vial for Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glass Vial for Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Glass Vial for Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glass Vial for Vaccine Value Chain Analysis
- 8.1.1 Glass Vial for Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glass Vial for Vaccine Production Mode & Process
- 8.2 Glass Vial for Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glass Vial for Vaccine Distributors
- 8.2.3 Glass Vial for Vaccine Customers
9 Global Glass Vial for Vaccine Analyzing Market Dynamics
- 9.1 Glass Vial for Vaccine Industry Trends
- 9.2 Glass Vial for Vaccine Industry Drivers
- 9.3 Glass Vial for Vaccine Industry Opportunities and Challenges
- 9.4 Glass Vial for Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst